Eton Pharmaceuticals Inc (NASDAQ: ETON) is 190.87% higher on its value in year-to-date trading and has touched a low of $3.03 and a high of $12.54 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ETON stock was last observed hovering at around $12.45 in the last trading session, with the day’s gains setting it 0.29%.
Currently trading at $12.74, the stock is 27.34% and 52.18% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.19 million and changing 2.33% at the moment leaves the stock 156.26% off its SMA200. ETON registered 241.55% gain for a year compared to 6-month gain of 251.93%. The firm has a 50-day simple moving average (SMA 50) of $8.2348 and a 200-day simple moving average (SMA200) of $4.9299.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 49.18% loss in the last 1 month and extending the period to 3 months gives it a 176.96%, and is 22.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.56% over the week and 7.17% over the month.
Eton Pharmaceuticals Inc (ETON) has around 30 employees, a market worth around $329.15M and $34.68M in sales. Fwd P/E is 30.33. Profit margin for the company is -15.81%. Distance from 52-week low is 320.46% and 1.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.03%).
The EPS is expected to shrink by -237.50% this year
The shares outstanding are 25.69M, and float is at 24.46M with Short Float at 0.84%.
The top institutional shareholder in the company is OPALEYE MANAGEMENT INC. with over 2.4 million shares valued at $7.88 million. The investor’s holdings represent 9.2963 of the ETON Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.03 million shares valued at $3.38 million to account for 3.989 of the shares outstanding. The other top investors are NANTAHALA CAPITAL MANAGEMENT, LLC which holds 0.94 million shares representing 3.6515 and valued at over $3.1 million, while WESTSIDE INVESTMENT MANAGEMENT, INC. holds 2.2723 of the shares totaling 0.59 million with a market value of $1.93 million.
Eton Pharmaceuticals Inc (ETON) Insider Activity
The most recent transaction is an insider purchase by Opaleye Management Inc., the company’s 10% Owner. SEC filings show that Opaleye Management Inc. bought 10,000 shares of the company’s common stock on Oct 23 ’24 at a price of $7.98 per share for a total of $79814.0. Following the purchase, the insider now owns 2.77 million shares.
Eton Pharmaceuticals Inc disclosed in a document filed with the SEC on Oct 08 ’24 that Opaleye Management Inc. (10% Owner) bought a total of 33,970 shares of the company’s common stock. The trade occurred on Oct 08 ’24 and was made at $7.03 per share for $0.24 million. Following the transaction, the insider now directly holds 2.76 million shares of the ETON stock.
Still, SEC filings show that on Oct 04 ’24, Opaleye Management Inc. (10% Owner) acquired 16,852 shares at an average price of $6.77 for $0.11 million. The insider now directly holds 2,720,000 shares of Eton Pharmaceuticals Inc (ETON).
